MRX Financial Facts
Net income (loss): 937KBasic net income (loss) per share: 0.02
See Full Income Statement
Common stock: 0
Preferred stock: 0
See Full Balance Sheet
Medicis Pharmaceutical Corp. (MRX) Earnings
|
Expand Research on MRX
| Next EPS Date | 8/13/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +11.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/26  |
Q126 | N/A | $1.02 | N/A | N/A | $527.88M | N/A | N/A | N/A | ||
| 3/3/26 | Q425 | $1.13 | $0.99 | +$0.14 | $572.1M | $508.62M | N/A |  | | Details | |
| 11/6/25 | Q325 | $0.96 | $0.94 | +$0.02 | $484.6M | $475.84M | N/A | | | Details | |
| 8/13/25 | Q225 | $1.02 | $0.93 | +$0.09 | $500.1M | $470.53M | N/A | | | Details | |
| 5/15/25 | Q125 | $0.91 | $0.77 | +$0.14 | $467.3M | $428.46M | N/A | | | Details | |
| 3/6/25 | Q424 | $0.76 | $0.61 | +$0.15 | $415.6M | $370.72M | N/A | | | Details | |
| 11/7/24 |
Q324 | N/A | $0.67 | N/A | N/A | $371.26M | N/A | N/A | N/A | ||
| 8/14/24 | Q224 | $0.90 | $0.57 | +$0.33 | $422.1M | $348.85M | N/A | | | Details |
